These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9027653

  • 1. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.
    Matsuda K, Watanabe H, Ajioka Y, Kobayashi M, Saito H, Sasaki M, Yasuda K, Kuwabara A, Nishikura K, Muto T.
    J Gastroenterol; 1996 Dec; 31(6):860-7. PubMed ID: 9027653
    [Abstract] [Full Text] [Related]

  • 2. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
    Sato A, MacHinami R.
    Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
    [Abstract] [Full Text] [Related]

  • 3. Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case.
    Sada H, Shimomura M, Hinoi T, Egi H, Kawaguchi K, Yano T, Niitsu H, Saitou Y, Sawada H, Miguchi M, Adachi T, Ohdan H.
    World J Surg Oncol; 2015 Mar 26; 13():123. PubMed ID: 25888857
    [Abstract] [Full Text] [Related]

  • 4. Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma.
    Fogt F, Zhuang Z, Poremba C, Dockhorn-Dworniczak B, Vortmeyer A.
    Oncol Rep; 1998 Mar 26; 5(2):477-80. PubMed ID: 9468583
    [Abstract] [Full Text] [Related]

  • 5. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
    Maruyama K, Saigusa N, Baba S, Kino I.
    Gan To Kagaku Ryoho; 1995 Jun 26; 22 Suppl 2():145-8. PubMed ID: 7611778
    [Abstract] [Full Text] [Related]

  • 6. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
    Mitsuhashi J, Mikami T, Saigenji K, Okayasu I.
    Pathol Int; 2005 Mar 26; 55(3):113-21. PubMed ID: 15743319
    [Abstract] [Full Text] [Related]

  • 7. Assessment of dysplasia, mucosal mucins, p53 protein expression, and DNA content in ulcerative colitis patients with colectomy and ileorectal anastomosis.
    Navratil E, Stettler C, Paul G, Vilotte J, Vissuzaine C, Mignon M, Potet F.
    Scand J Gastroenterol; 1995 Apr 26; 30(4):361-6. PubMed ID: 7610353
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for carcinoma of the pelvic ileal pouch/anal canal in ulcerative colitis.
    Elkowitz D, Daum F, Markowitz J, Proccaccino J, Boas E, Cuomo J, Kahn E.
    Ann Clin Lab Sci; 2004 Apr 26; 34(2):143-9. PubMed ID: 15228225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis.
    Popp C, Nichita L, Voiosu T, Bastian A, Cioplea M, Micu G, Pop G, Sticlaru L, Bengus A, Voiosu A, Mateescu RB.
    Dis Markers; 2016 Apr 26; 2016():3625279. PubMed ID: 27578918
    [Abstract] [Full Text] [Related]

  • 14. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.
    Wong NA, Mayer NJ, Anderson CE, McKenzie HC, Morris RG, Diebold J, Mayr D, Brock IW, Royds JA, Gilmour HM, Harrison DJ.
    Hum Pathol; 2003 Jun 26; 34(6):580-8. PubMed ID: 12827612
    [Abstract] [Full Text] [Related]

  • 15. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.
    Arai N, Mitomi H, Ohtani Y, Igarashi M, Kakita A, Okayasu I.
    Mod Pathol; 1999 Jun 26; 12(6):604-11. PubMed ID: 10392637
    [Abstract] [Full Text] [Related]

  • 16. pS2 expression as a possible diagnostic marker of colorectal carcinoma in ulcerative colitis.
    Hirota Y, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N.
    Oncol Rep; 2000 Jun 26; 7(2):233-9. PubMed ID: 10671663
    [Abstract] [Full Text] [Related]

  • 17. p53 mutation in patients with ulcerative colitis in rectal biopsy.
    Kim HJ, Chang SK.
    Korean J Intern Med; 1998 Jul 26; 13(2):110-6. PubMed ID: 9735666
    [Abstract] [Full Text] [Related]

  • 18. Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis.
    Taylor HW, Boyle M, Smith SC, Bustin S, Williams NS.
    Br J Surg; 1993 Apr 26; 80(4):442-4. PubMed ID: 8495305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Morphological and immunohistochemical quantitative analysis of dysplasia in ulcerative colitis. 1. Histological mapping specimen and morphological quantitative analysis].
    Oikawa T.
    Nihon Shokakibyo Gakkai Zasshi; 1992 Feb 26; 89(2):477-85. PubMed ID: 1569702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.